E-drug: Contents of Prescrire International, June 2001
-------------------------------------------------------------------------
Prescrire International is the English language edition of La revue
Prescrire. It contains comprehensive evaluations of new drugs and
new indication, and reviews of adverse effects and therapeutic
interventions. Prescrire International is published six times a year.
Contents of Prescrire International
June 2001 Volume 10, No 53
EDITORIAL
WHO essential drugs, except for the poor
NEW PRODUCTS
C1 esterase inhibitor (new preparation)
A major advance in hereditary angioneurotic oedema
Amprenavir (new preparation)
No proven advance for treating HIV infection
Leuprorelin and triptorelin (new indication)
No proven use before surgery for leiomyoma
Anastrazole (licence extension)
No advantage over tamoxifen
Verteporfin (new preparation)
Helpful in age-related macular degeneration
ADVERSE EFFECTS
Ocular adverse effects of alendronic acid
Rare cases of anterior uveitis
Adverse effects of rofecoxib (continued)
Differ little from other NSAIDs
Myocarditis due to clozapine
Another reason for using clozapine as a last resort
REVIEWS
Acupuncture
More stringent assessment needed
Intrauterine devices
No antibiotic prophylaxis for insertion
OUTLOOK
Essential drugs concept: still valid
SHORTCUTS
. Medical treatment of chronic heart failure.
. Antiinflammatory + antimicrobial eye drops for cataract surgery.
Persona
. Pravastatin in heart transplantation. Sodium phenylbutyrate
Since January 2001, we have created Solidarity Subscription Rates
for low income countries, so that health professionals in such
countries can also use our source of independent information. The
Solidarity Rates apply to all subscribers who live in low income
countries, excluding pharmaceutical companies.
Standard Subscription Rates:
Individuals: 85 USD (FF 600 or 91,47 Euros)
Students: 45 USD (FF 300 or 45,73 Euros)
Commercial institutions: 210 USD (FF 1500 or 228,67 Euros)
Solidarity Subscription Rates for countries with GNP <10,000 USD:
Individuals: 35 USD (FF 250 or 38,11 Euros)
Students: 21 USD (FF 150 or 27,87 Euros)
Institutions: 85 USD (FF 600 or 91,47 Euros) (except for
pharmaceutical companies).
The following countries are not eligible for Solidarity Subscription
Rates: Australia, Austria, Belgium, Brunei, Canada, Cyprus,
Denmark, Finland, France, Germany, Greece, Hong Kong, Iceland,
Ireland, Italy, Japan, Liechtenstein, Luxemburg, Monaco, the
Netherlands, New Zealand, Norway, Portugal, Singapore, Spain,
Sweden, Switzerland, United Kingdom, United States of America.
La revue Prescrire
BP 459
75527 Paris Cedex 11
France
Tel. 33 1 49 23 72 63
Fax 33 1 48 07 87 32
Email: international@prescrire.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://satellife.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.